Ireland· IE-PA-PA2028/003/001
Peglax 10 g powder for oral solution in sachet
A macrogol product containing macrogol 4000, registered in Ireland by Casen-Recordati S.L.. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Macrogol is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AD15 (macrogol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Macrogol · ATC A06AD15
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
Price per daily dose
What a daily dose of macrogol costs, country by country.
Normalised to the WHO defined daily dose (10 g), the median price runs from $0.083 in Finland to $0.66 in Switzerland — a ×7.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Macrogol · price per daily dose (10 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.66
- FI Finland$0.083
The record
At a glance
HPRA (Ireland)- Active substance
- Macrogol 4000
- Manufacturer
- Casen-Recordati S.L.
- Country
- Ireland (IE)
- ATC code
- A06AD15
- ATC class
- Macrogol
- Defined daily dose
- 10 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2028/003/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
449 interactions on record for macrogol.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macrogol · interactions on record
449 records
- 37 severe
- 411 moderate
- 1 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Macrogol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceFORLAX 10 g, poudre pour solution buvable en sachetMAYOLY PHARMA FRANCE
- NetherlandsForlax 10 g, poeder voor drank in sachetEU-Pharma B.V.
- PolandForlax 10 gPharmapoint SA
- FinlandCasenlaxCasen Recordati, S.L.
- SwedenCasenlax 10 g Pulver till oral lösning i dospåseCasen Recordati, S.L.
- BelgiumDulcosoft 10 gSanofi Belgium
- CzechiaFORLAXMayoly Pharma France, Rueil-Malmaison
- GermanyForlaxIpsen Consumer Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Forlax, Macrogol 4000 Strides
- Belgium · Forlax, Forlax Junior
- Bulgaria · Касенлакс
- Cyprus · Macrogol 4000 Casen Recordati
- Czechia · Forlax
- Germany · Forlax, Laxatan
- Denmark · Casenlax, Macrogol 4000 Strides
- Estonia · Forlax, Proctolax
- Spain · Casenlax, Femlax
- Finland · Casenlax, Makrogoli Orion
- France · Forlax, Macrogol 4000 Arrow
- United Kingdom (Northern Ireland) · Dulcobalance, Peglax
- Greece · Cleenlax, Cleenlax Forte
- Italy · Casenjunior, Casenlax
- Lithuania · Forlax, Macrogol 4000 Casen Recordati
- Luxembourg · Forlax, Forlax Junior
- Latvia · Forlax, Proctolax
- Netherlands · Forlax, Forlax Junior
- Norway · Casenlax, Golax
- Poland · Forlax, Macrogol Aurovitas
- Portugal · Casenlax, Forlax
- Romania · Forlax, Proctolax
- Sweden · Casenlax, Forlax
- Slovakia · Forlax, Laxatan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c7515617-a279-483b-8dd2-040912cce5b6 GET /v1/drugs/c7515617-a279-483b-8dd2-040912cce5b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A06AD",
"A06AD15"
],
"strength": null,
"pa_number": "PA2028/003/001",
"substances": [
"Macrogol 4000"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "28/06/2013",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about macrogol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.